In patients with refractory angina and coronary microvascular dysfunction but no obstructed coronary arteries, a coronary ...
Late-breaking data presented at TCT 2026 and published simultaneously in JACC: Cardiovascular Interventions show durable benefit with MagicTouch PTA, with similar walking capacity, quality of life and ...
Abbott has posted positive 30-day results from its Tectonic trial of the investigational SonicForce Coronary IVL System in ...
A major international clinical trial has delivered a significant boost to the case for stent-free coronary intervention, finding that sirolimus-coated balloon (SCB) angioplasty is non-inferior to ...
– Founder & CEO Laura Niklason, M.D., Ph.D., to deliver invited talk on engineering the microenvironment to accelerate vascular regeneration. – Two additional presentations to cover first-in-human ...
Conavi Medical Corp. ( CNVI.V ), a commercial-stage medical device company, on Monday announced the completion of the first U.S. placement of OCTIV, a hybrid intravascular imaging system used in ...
A basic cholesterol panel doesn’t measure this certain inherited factor that can raise your risk for heart disease.
Incomplete Kawasaki disease (IKD) remains hard to recognize because it often lacks the classic signs of complete Kawasaki disease (CKD), yet delayed diagnosis can lead to coronary artery damage.
Kawasaki DiseasePediatric LabsLab Interpretation No single blood test confirms Kawasaki disease. Diagnosis combines fever history, examination, inflammatory markers, supporting laboratory findings, ...
Presented at the Transcatheter Cardiovascular Therapeutics conference in San Diego, both trials logged low complication rates ...
First-in-Human Percutaneous Coronary Intervention procedures with next-generation robotic systemRobocath system demonstrates ability to efficiently and effectively support the full range of coronary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results